Low ZHX2 is associated with poor prognosis in chronic lymphocytic leukemia and multiple myeloma (MM) (8, 54), while higher ZHX2 mRNA correlates with better overall survival in patients with breast cancer (55) and thyroid cancer (7). The gene discussed is ZHX2; the disease is B-cell chronic lymphocytic leukemia.